FLAURA2

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

FLAURA2

Oct 6, 2024, 13:47 | Blog

Ana I. Velázquez Mañana: Lung Cancer management updates from 2024 by Weill Cornell Medicine Meyer Cancer Center

Ana I. Velázquez Mañana shared a post on X: ''Christine Garcia from Weill Cornell Medicine…

Sep 29, 2024, 06:34 | Insight

Picks from Lung Cancer Cocktail With Science by Stephen V Liu

The Lung Cancer Cocktail With Science 2024 conference took place on September 27th in Milan,…

Aug 28, 2024, 19:52 | Blog

Impact of baseline positive vs negative plasma Circulating tumor DNA for Estimated glomerular filtration rate in the FLAURA2 trial by Jonathan Riess

David Gandara, Co-Director-Center for Experimental Therapeutics, shared a post on X: "At Cal Cancer Consortium…

Aug 24, 2024, 11:15 | Insight

Jill Feldman: Exciting news for the EGFR lung cancer community

Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Jill Feldman on…

Aug 23, 2024, 14:21 | Drugs

Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?

Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…

Jul 18, 2024, 10:05 | Insight

EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer

Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…

May 3, 2024, 04:28 | Blog

Erman Akkus: Roundup of the last year-Practice changing trials in NSCLC

Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X/Twitter: "Roundup…

Apr 26, 2024, 09:26 | Insight

Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2

Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter: ''First-line treatment…

Apr 21, 2024, 18:13 | Blog

Antonio Passaro: An intense yet incredibly rewarding day in Oporto

Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared a…

Apr 13, 2024, 09:17 | Societies

30 Posts Not To Miss From AACR24!

The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…

Feb 17, 2024, 15:57 | Insight

Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.

Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Hot off…

All: 11 Posts: 1 - 100